Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.04
67% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $191.5K | $410.9K | $205.7K | $2.9M | $3.1M | $5.0M | $2.7M | $0 |
| Cost of revenue | $3.3M | $2.3M | $2.9M | $2.7M | $3.6M | $5.3M | $401.0K | $8.8K |
| Gross profit | −$3.1M | −$1.9M | −$2.7M | $151.5K | −$544.9K | −$279.8K | $2.3M | −$8.8K |
| Gross margin | -1621.2% | -452.3% | -1290.6% | 5.3% | -17.7% | -5.6% | 85.0% | — |
| R&D | $3.3M | $2.3M | $2.9M | $2.7M | $3.6M | $5.3M | $401.0K | $2.1M |
| Operating income | −$8.3M | −$3.4M | −$7.8M | −$8.3M | −$12.1M | −$15.8M | −$756.6K | −$3.6M |
| EBITDA | −$8.1M | −$3.3M | −$5.2M | −$5.6M | −$9.5M | −$10.3M | −$700.1K | −$3.6M |
| Net income | −$8.3M | −$3.4M | −$5.4M | −$6.0M | −$9.8M | −$12.5M | −$2.1M | −$4.3M |
| Net margin | -4359.7% | -835.5% | -2607.5% | -211.0% | -319.4% | -250.9% | -77.6% | — |
| EPS (diluted) | -0.04 | -0.61 | -0.29 | -0.24 | -0.35 | -0.41 | -0.05 | -0.02 |
Annual figures · source: Financial Modeling Prep
IMAGION BIOSYSTEMS LTD
No one on the platform currently holds IBXXF.
No tracked institution reports a position in IBXXF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-11-16 | 1-for-40reverse |
No one on the platform has traded IBXXF yet.
| $2M |
| — |
| GENPFGenix Pharmaceuticals Corporation | $0.02 | +0.00% | $924484 | — |
| IGEXIndo Global Exchange(s) PTE, Ltd. | $0.00 | +0.00% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.4× sales vs its 5.0× historical median P/S.
Fair value ≈ $0.36 · price $0.03 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$IBXXF https://imagionbiosystems.com/news/preliminary-performance-of-phase-i-study-magsense-her2-imaging-agent/?mibextid=Zxz2cZ
View on StockTwits ↗$IBXXF 👀 https://imagionbiosystems.com/news/prestige-biopharma-and-imagion-biosystems-sign-an-mou-developing-early-pancreatic-cancer-diagnosis-platform/
View on StockTwits ↗$IBXXF Watcher #3… 3 is a magic number, or did you forget your Schoolhouse Rock?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.